Ligand | EC50 (Potency Relative to DAMGO)a | ||||||||
---|---|---|---|---|---|---|---|---|---|
Gαi3 | GαoA | Gαi1 | Gαi2 | Gαi2/Gαi3 | |||||
nM | |||||||||
DAMGO | 28 ± 9 (1.0 ± 0.3) | 48 ± 9 (1.0 ± 0.2) | 207 ± 73 (1.0 ± 0.4) | 145 ± 36 (1.0 ± 0.2) | 5.2 | ||||
Etorphine | 0.30 ± 0.02 (0.014 ± 0.001) | 0.45 ± 0.07 (0.010 ± 0.002) | 0.94 ± 0.08 (0.005 ± 0.0004) | 1.3 ± 0.1 (0.009 ± 0.0002) | 4.3 | ||||
Fentanyl | 33 ± 12 (1.2 ± 0.4) | 59 ± 18 (1.2 ± 0.4) | 151 ± 50 (0.7 ± 0.2) | 170 ± 30 (1.2 ± 0.2) | 5.2 | ||||
Endomorphin-1 | 28 ± 2 (1.0 ± 0.1) | 71 ± 4 (1.5 ± 0.1) | 112 ± 3 (0.54 ± 0.02) | 134 ± 11 (0.92 ± 0.10) | 4.9 | ||||
Endomorphin-2 | 45 ± 5 (1.6 ± 0.2) | 132 ± 28 (2.8 ± 0.6) | 206 ± 57 (1.0 ± 0.3) | 219 ± 33 (1.5 ± 0.2) | 4.9 | ||||
Morphine | 31 ± 6 (1.1 ± 0.2) | 57 ± 17 (1.2 ± 0.4) | 168 ± 109 (0.82 ± 0.53) | 162 ± 61 (1.1 ± 0.4) | 5.2 | ||||
Meperidine | 3550 ± 960 (130 ± 30) | 5020 ± 1340 (110 ± 30) | 11,200 ± 1680 (54 ± 8) | 8180 ± 740 (56 ± 5) | 2.3 |
↵ a Differences in the potency of ligands across the Gα proteins expressed were significant for DAMGO [F(3,8) = 4.2, P < 0.05], etorphine [F(3,8) = 38.8, P < 0.001] (Gαi3 = Gαo > Gai1, P < 0.01; Gαi3 = Gαo > Gai2, P < 0.001), fentanyl [F(3,8) = 4.7, P < 0.05], endomorphin-1 [F(3,8) = 58, P < 0.0001] (Gαi3 > Gαo, P < 0.01; Gαi3 = Gαi1, P < 0.001; Gαi3 > Gαi2, P < 0.001), endomorphin-2 [F(3,8) = 5.0, P < 0.05], and meperidine [F(3,8) = 7.6, P < 0.01]